Genetic engineering has been boosted by the discovery and characterization of CRIPSR-associated Cas9 RNA-guided endonuclease. This technology enables the rapid manipulation of genes as well as genome-wide functional screening. With broad basic science and translational applications, this technology is driving innovative life science and medical research around the world. To learn more about how Horizon's gene editing technology is supporting and advancing translational genomics research and the development of personalized medicines, or for help with any gene editing applications, please visit horizondiscovery.com
Horizon Discovery: Capitalizing on CRISPR
With broad basic science and translational applications, gene editing technology is driving innovative life science and medical research around the world.
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
